<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951143</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA042535</org_study_id>
    <nct_id>NCT02951143</nct_id>
  </id_info>
  <brief_title>Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Polytechnic Institute and State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tobacco regulatory policies can have unanticipated consequences; therefore, methods that
      would permit prospective estimates of the effects of potential tobacco regulations are
      necessary for the development of tobacco regulatory science. The goal of this project is to
      experimentally assess how smokers purchase and consume reduced-nicotine cigarettes. In
      experiment 1, we will investigate how purchasing/consuming reduced-nicotine cigarettes is
      related to nicotine content and absorption. In experiment 2, we will investigate how
      purchasing/consuming changes when other nicotine products are available in an experimental
      marketplace setting. The proposed projects can directly inform tobacco regulation by
      providing estimates of the real-world effects of novel policies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarette Purchase Task</measure>
    <time_frame>10 minutes after cigarette administration</time_frame>
    <description>The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in blood nicotine content</measure>
    <time_frame>Prior to and 0, 5, 10, 20, 35, and 50 minutes after cigarette administration</time_frame>
    <description>In experiment 1 only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Experimental Marketplace Purchases</measure>
    <time_frame>Sessions 2-5</time_frame>
    <description>In experiment 2 only, measures of quantities of experimental cigarettes and other nicotine products will be obtained.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">232</enrollment>
  <condition>Substance-Related Disorders</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will complete the same experimental events across 6 laboratory sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.4 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 0.4 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.4 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 1.4 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2.5 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 2.5 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5.6 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 5.6 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>17.4 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 17.4 mg/g Concentration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPECTRUM cigarettes</intervention_name>
    <description>Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 501) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 500) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPECTRUM cigarettes between</intervention_name>
    <description>Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
    <arm_group_label>0.4 mg/g Concentration</arm_group_label>
    <arm_group_label>1.4 mg/g Concentration</arm_group_label>
    <arm_group_label>2.5 mg/g Concentration</arm_group_label>
    <arm_group_label>5.6 mg/g Concentration</arm_group_label>
    <arm_group_label>17.4 mg/g Concentration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  smoke at least 5 cigarettes per day

          -  have a breath carbon monoxide (CO) level of at least 10 ppm at intake

          -  no immediate plans to quit smoking.

        Exclusion Criteria:

          -  pregnant, lactating, plans to become pregnant

          -  weigh more than 110lbs (experiment 1 only)

          -  have plans to move out of the area during the course of the experiment

        To see if you are eligible, use the following confidential link:
        http://vtcri.info/arrcclinicaltrials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brent Kaplan, PhD</last_name>
    <email>bkaplan4@vtc.vt.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Virginia Tech Carilion Research Institute</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brent Kaplan, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Mikhail N Koffarnus, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Warren K Bickel, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Virginia Polytechnic Institute and State University</investigator_affiliation>
    <investigator_full_name>Mikhail Koffarnus</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

